Les effets indésirables du Glucantime® en intralésionnel dans le traitement de la leishmaniose cutanée
- 4 April 2006
- journal article
- research article
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 36 (4) , 226-228
- https://doi.org/10.1016/j.medmal.2005.11.018
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Glucantime® par voie parentérale : bénéfice versus toxicitéMedecine Et Maladies Infectieuses, 2005
- High frequency of skin reactions in patients with leishmaniasis treated with meglumine antimoniate contaminated with heavy metals: a comparative approach using historical controlsMemórias do Instituto Oswaldo Cruz, 2003
- Treatment of cutaneous leishmaniasisJournal of the American Academy of Dermatology, 1994
- Dissemination in Cutaneous LeishmaniasisInternational Journal of Dermatology, 1988